Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pure Cycle (PCYO) Cash & Equivalents (2016 - 2025)

Pure Cycle (PCYO) has disclosed Cash & Equivalents for 16 consecutive years, with $17.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 9.96% to $17.1 million in Q4 2025 year-over-year; TTM through Nov 2025 was $17.1 million, a 9.96% decrease, with the full-year FY2025 number at $21.9 million, changed N/A from a year prior.
  • Cash & Equivalents was $17.1 million for Q4 2025 at Pure Cycle, down from $21.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $34.9 million in Q3 2022 to a low of $5.2 million in Q1 2022.
  • A 5-year average of $17.8 million and a median of $19.3 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: plummeted 74.54% in 2022, then skyrocketed 379.53% in 2023.
  • Pure Cycle's Cash & Equivalents stood at $12.9 million in 2021, then surged by 30.42% to $16.8 million in 2022, then increased by 29.34% to $21.8 million in 2023, then fell by 12.64% to $19.0 million in 2024, then dropped by 9.96% to $17.1 million in 2025.
  • Per Business Quant, the three most recent readings for PCYO's Cash & Equivalents are $17.1 million (Q4 2025), $21.9 million (Q3 2025), and $14.4 million (Q2 2025).